BRIEF-Allergan says FDA accepts premarket notification filing for glaucoma treatment

Wed Jun 15, 2016 7:41am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 15 (Reuters) - Allergan Plc :

* "Look forward to working together with FDA" to bring glaucoma treatment system to market

* Allergan announces FDA acceptance of the 510(k) premarket notification filing for the XEN glaucoma treatment system Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)